| Schedule of share-based compensation activity |
| | | | | | | | | | | | | Weighted | | | | Weighted | | | | | Average | | | | Average | | | | | Grant-Date | | Time Based | | Grant-Date | | Performance | | | Fair Value | | Units | | Fair Value | | Based Units | Outstanding and non-vested at December 31, 2021 | | $ | 9.20 | | 5,471,400 | | $ | — | | — | Granted during period | | | — | | — | | | — | | — | Vested | | | 9.20 | | 549,822 | | | — | | — | Cancelled/forfeited | | | — | | — | | | — | | — | Outstanding and non-vested at March 31, 2022 | | $ | 9.20 | | 4,921,578 | | $ | — | | — |
|
| Schedule of time-based stock option activities |
| | | | | | | | | | | | | Weighted | | | | | | | Average | | | Number of | | Weighted | | Remaining | | | Options | | Average | | Contractual | | | Outstanding | | Exercise Price | | Life (Years) | Outstanding and non-vested at December 31, 2021 | | — | | — | | — | Granted | | 2,034,279 | | 6.43 | | 2.99 | Vested | | — | | — | | — | Cancelled/forfeited | | — | | — | | — | Outstanding and non-vested at March 31, 2022 | | 2,034,279 | | 6.43 | | 2.99 |
|